Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Quercegen Agronegocios is the Brazilian-based agricultural and sourcing division of Quercegen Pharma, dedicated to the sustainable production of high-purity quercetin. The company manages the entire supply chain for the Dimorphandra mollis (Fava D'Anta) tree, ensuring the ethical harvest and primary extraction of raw flavonoids in the Cerrado region. This vertical integration supports the production of QU995, a proprietary, pharmaceutical-grade quercetin anhydrous used in numerous clinical trials. Quercegen's research focuses on the therapeutic potential of quercetin in treating cardiovascular disease, chronic inflammation, and its role as a senolytic agent. By combining traditional agribusiness with modern biotechnology, the company provides standardized bioactive compounds for the global healthcare and nutraceutical markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Quercegen Agronegocios.